Literature DB >> 9448103

Enzymes responsible for the metabolism of saikosaponins from Eubacterium sp. A-44, a human intestinal anaerobe.

H Kida1, T Akao, M R Meselhy, M Hattori.   

Abstract

From a human intestinal bacterium, Eubacterium sp. A-44, which is capable of hydrolyzing saikosaponins to saikogenins, two glycosidases, beta-D-glucosidase and a novel type of beta-D-fucosidase, were isolated and characterized as saikosaponin-hydrolyzing beta-D-glucosidase and prosaikogenin-hydrolyzing beta-D-fucosidase. Relative to the hydrolyzing activities toward saikosaponins a, b1 and b2, the beta-D-glucosidase showed lower ability to hydrolyze saikosaponin d, but no ability to hydrolyze saikosaponin c or prosaikogenins. By Sephacryl S-300 column chromatography, the molecular weight of prosaikogenin-hydrolyzing beta-D-fucosidase was estimated to be about 130 kDa. The beta-D-fucosidase could hydrolyze prosaikogenins A and F, but not prosaikogenins D and G or saikosaponins. Relative to p-nitrophenyl beta-D-fucoside-hydrolyzing activity, this enzyme had 32.0% and 22.2% of its hydrolyzing ability toward p-nitrophenyl beta-D-glucoside and p-nitrophenyl beta-D-galactoside, respectively. p-Nitrophenyl beta-D-fucoside-hydrolyzing activity was inhibited by D-fucose, and was weakly inhibited by D-glucose, D-glucono delta-lactone, D-galactose and D-galactono delta-lactone. By combining these two glycosidases, saikosaponins a and b1 were converted to their saikogenins via the corresponding prosaikogenins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9448103     DOI: 10.1248/bpb.20.1274

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

Review 1.  A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins.

Authors:  Xiaojiaoyang Li; Xiaoyu Li; Nana Huang; Runping Liu; Rong Sun
Journal:  Phytomedicine       Date:  2018-09-17       Impact factor: 5.340

2.  Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.

Authors:  Sho Kawaguchi; Kenta Kawahara; Yukio Fujiwara; Koji Ohnishi; Cheng Pan; Hiromu Yano; Akiyuki Hirosue; Masashi Nagata; Masatoshi Hirayama; Junki Sakata; Hikaru Nakashima; Hidetaka Arita; Keisuke Yamana; Shunsuke Gohara; Yuka Nagao; Manabu Maeshiro; Asuka Iwamoto; Mayumi Hirayama; Ryoji Yoshida; Yoshihiro Komohara; Hideki Nakayama
Journal:  Cancer Immunol Immunother       Date:  2022-01-19       Impact factor: 6.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.